Nasal Decongestant (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nasal Decongestant, is an alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Nasal Decongestant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride works on the nasal mucosa to reduce swelling and improve airflow in several common conditions.

Common cold nasal congestion: decreases mucosal edema to ease breathing during a cold. Sinusitis‑related congestion: reduces sinus pressure by constricting nasal blood vessels. Allergic rhinitis: alleviates nasal blockage caused by allergic inflammation.

Oxymetazoline Hydrochloride may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing or mild itching - Headache - Transient taste disturbance

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) with prolonged use - Elevated blood pressure or hypertension - Palpitations or tachycardia - Severe allergic reaction (anaphylaxis) - Nasal ulceration or crusting

Oxymetazoline Hydrochloride should be used with awareness of specific safety considerations.

Limit duration: Do not exceed three consecutive days of use to avoid rebound congestion. Pregnancy and lactation: Use only if clearly needed and after professional advice. Underlying cardiovascular disease: Monitor blood pressure if the product is used. Children under 6 years: Not recommended unless directed by a healthcare professional. Drug interactions: Avoid concurrent use with other nasal decongestants or sympathomimetic agents. Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with other medicines that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: may precipitate hypertensive crisis. - Other nasal decongestants: additive vasoconstriction increases risk of rebound congestion. - Sympathomimetic drugs (e.g., epinephrine): can cause excessive vasoconstriction and hypertension.

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: monitor for changes in heart rate or blood pressure. - Tricyclic antidepressants: may augment vasoconstrictive response.